ALFA FinderBSE filing, NSE: NILE. Summary written from the filing by ALFA Finder's alert engine.
Nile Ltd: key numbers
- Share price
- ₹1,410.70
- Market cap
- ₹423.5 Cr
- Revenue (annual)
- ₹1,041 Cr
- Net profit (annual)
- ₹55.26 Cr
- P/E (TTM)
- 6.7×Sector 16.9×
- Promoter holding
- 50.39%+0.00% QoQ
- FII holding
- 0.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nile Ltd
All →Nile Dividend
Nile Ltd set 17 November 2026 as the record date for its Re 3 per share interim dividend. The dividend covers FY 2026-27 and 30,01,900 shares.
Nile Q2 FY27 Results: Net Profit ₹2.7 Cr, Down 76.7% YoY
Nile Ltd reported revenue from operations of ₹221.7 Cr (-19.1% YoY) and net profit of ₹2.7 Cr (-76.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.7 Cr · -76.7% YoY
Nile Other Announcement
Nile Ltd filed a SEBI-mandated report on physical-share transfer re-lodgement. All requests for October 2026 were NIL.
Nile Board Meeting Date
Nile Ltd intimated a Board Meeting on 10th November, 2026. Agenda includes Q2 results and an interim dividend, both proposed only.
Nile Management Change
Nile Limited announced the re-appointment of Mr. Sandeep Vuyyuru Ramesh as Executive Director for 36 months. M/s M. Bhaskara Rao & Co was also appointed as Statutory Auditor.
- Execution
- 36 months
Nile Other Announcement
Nile Ltd shareholders approved the appointment of M/s M. Bhaskara Rao & Co as Statutory Auditors. The firm will serve for a five-year term ending in 2031.
- Execution
- 5 years
Other financial results announcements
All →Rentomojo Q2 FY27 Results: Net Profit ₹18.2 Cr, Down 62.6% YoY
Rentomojo Ltd's board approved Q2 FY27 unaudited standalone and consolidated results, a remuneration revision for Ketan Krishna and KMPs/SMPs, and an issue-proceeds utilisation statement. The filing is primarily financial results, with the Q2 results statement and limited review reports enclosed.
- Key figure
- Net profit ₹18.2 Cr · -62.6% YoY
Cell Point (India) H1 FY27 Results: Net Profit ₹0.4 Cr, Up 100.0% YoY
Cell Point (India) Ltd reported revenue from operations of ₹190.4 Cr (+7.6% YoY) and net profit of ₹0.4 Cr (+100.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹0.4 Cr · +100.0% YoY
Avience Biomedicals H1 FY27 Results: Net Profit ₹5.5 Cr, Up 22.2% YoY
Avience Biomedicals Ltd reported revenue from operations of ₹31.1 Cr (+16.0% YoY) and net profit of ₹5.5 Cr (+22.2% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.5 Cr · +22.2% YoY
Titagarh Rail Systems Q2 FY27 Results: Net Profit ₹63.2 Cr, Up 49.1% YoY
Titagarh Rail Systems Ltd reported revenue from operations of ₹792.6 Cr (-0.8% YoY) and net profit of ₹63.2 Cr (+49.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹63.2 Cr · +49.1% YoY
Virinchi Q2 FY27 Results: Net Loss of ₹19.5 Cr, Loss Widens
Virinchi Ltd reported revenue from operations of ₹73.9 Cr (+19.6% YoY) and a net loss of ₹19.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹19.5 Cr
Skybiotech Healthcare Q2 FY27 Results: Net Loss of ₹0.8 Cr, Loss Widens
Skybiotech Healthcare Ltd reported revenue from operations of ₹1 Cr (-47.4% YoY) and a net loss of ₹0.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.8 Cr